UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (2345) 2345
science & technology (2048) 2048
life sciences & biomedicine (1970) 1970
rats (1842) 1842
oxidopamine - toxicity (1731) 1731
neurosciences (1526) 1526
neurosciences & neurology (1513) 1513
male (1429) 1429
parkinson's disease (1117) 1117
rats, sprague-dawley (815) 815
6-hydroxydopamine (752) 752
disease models, animal (751) 751
dopamine - metabolism (625) 625
dopamine (599) 599
neurons - drug effects (490) 490
humans (475) 475
neurology (461) 461
rats, wistar (460) 460
oxidopamine (458) 458
tyrosine 3-monooxygenase - metabolism (455) 455
corpus striatum - drug effects (422) 422
female (400) 400
mice (398) 398
adrenergic agents - toxicity (389) 389
substantia nigra - drug effects (369) 369
dose-response relationship, drug (340) 340
parkinson’s disease (337) 337
motor activity - drug effects (335) 335
biochemistry & molecular biology (331) 331
corpus striatum - metabolism (329) 329
neurons (317) 317
neuroprotective agents - pharmacology (316) 316
time factors (314) 314
neurons - metabolism (312) 312
pharmacology & pharmacy (302) 302
6-ohda (279) 279
neuroprotection (274) 274
analysis (271) 271
parkinson disease - etiology (265) 265
substantia nigra - metabolism (252) 252
nervous system (247) 247
oxidopamine - pharmacology (247) 247
sympatholytics - toxicity (242) 242
cell survival - drug effects (231) 231
parkinson disease - pathology (222) 222
analysis of variance (218) 218
parkinsonian disorders - chemically induced (216) 216
cell biology (213) 213
behavior, animal - drug effects (210) 210
immunohistochemistry (208) 208
oxidative stress (208) 208
parkinson disease - drug therapy (204) 204
apoptosis (202) 202
parkinson disease - metabolism (200) 200
substantia nigra - pathology (200) 200
movement disorders (191) 191
substantia nigra (189) 189
biomedicine (185) 185
cells, cultured (183) 183
apoptosis - drug effects (181) 181
mice, inbred c57bl (177) 177
striatum (177) 177
corpus striatum - pathology (176) 176
neurons - physiology (176) 176
parkinsonian disorders - metabolism (175) 175
cell line, tumor (165) 165
dopaminergic neurons - drug effects (165) 165
dopamine - physiology (163) 163
parkinsonian disorders - drug therapy (162) 162
phenols (162) 162
parkinsonian disorders - physiopathology (161) 161
neurons - pathology (160) 160
parkinson disease, secondary - chemically induced (159) 159
rodents (157) 157
neurodegenerative diseases (155) 155
parkinsons disease (154) 154
apomorphine - pharmacology (153) 153
pc12 cells (152) 152
parkinson disease - physiopathology (148) 148
neurodegeneration (147) 147
parkinsonian disorders - pathology (147) 147
neurotoxins - toxicity (141) 141
oxidative stress - drug effects (140) 140
brain - drug effects (139) 139
reactive oxygen species - metabolism (138) 138
brain - metabolism (136) 136
rats, inbred strains (134) 134
dopaminergic neurons - metabolism (128) 128
clinical neurology (127) 127
basal ganglia (126) 126
cell death - drug effects (125) 125
gene expression regulation - drug effects (123) 123
hydroxydopamines - toxicity (123) 123
cell line (120) 120
functional laterality (118) 118
nervous system diseases (118) 118
rat (118) 118
neurochemistry (117) 117
drug interactions (116) 116
levodopa - pharmacology (116) 116
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2483) 2483
Russian (15) 15
Japanese (13) 13
Chinese (7) 7
Spanish (3) 3
French (2) 2
German (1) 1
Portuguese (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The FEBS journal, ISSN 1742-464X, 04/2012, Volume 279, Issue 7, pp. 1156 - 1166
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 06/2014, Volume 9, Issue 6, pp. e100286 - e100286
Background: Mounting evidence shows that urate may become a biomarker of Parkinson's disease (PD) diagnosis and prognosis and a neuroprotectant candidate for... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Hydrogen Peroxide - toxicity | Cell Line | Signal Transduction | Humans | Protein Transport - drug effects | Gene Knockdown Techniques | Gene Expression Regulation - drug effects | Proteolysis - drug effects | Oxidopamine - toxicity | Neuroprotective Agents - pharmacology | Ubiquitination - drug effects | RNA Interference | Models, Biological | Uric Acid - pharmacology | Dopaminergic Neurons - metabolism | NF-E2-Related Factor 2 - metabolism | Cell Line, Tumor | Dopaminergic Neurons - drug effects | NF-E2-Related Factor 2 - genetics | Transcription, Genetic | Active Transport, Cell Nucleus | Neuroprotection | Cell culture | Neurosciences | Transcription factors | Hydrogen peroxide | Parkinson's disease | Transcription | Laboratories | Toxicity | Hydrogen | Parkinsons disease | Kinases | Neuroprotective agents | Degradation | Proteins | Antioxidants | Neurotoxicity | Ubiquitination | Rodents | Heme | Pretreatment | Catalysis | Damage accumulation | Movement disorders | Glutathione | Dopamine receptors | Glutamate-cysteine ligase | Translocation | Enzymes | Immunoglobulins | Dopamine | Neurodegenerative diseases | Neurons | 6-Hydroxydopamine | Heme oxygenase (decyclizing) | siRNA | Uric acid | Gene expression | Nuclear transport | Augmentation | Studies | Oxygenase | Neurology | Signaling | Molecular modelling | Biomarkers | Index Medicus
Journal Article
Journal of molecular neuroscience, ISSN 1559-1166, 10/2018, Volume 69, Issue 1, pp. 1 - 16
...Antioxidant and Anti-Apoptotic Activity of Octadecaneuropeptide Against 6-OHDA Toxicity in Cultured Rat Astrocytes Hadhemi Kaddour1,2,3 and Yosra Hamdi1... 
Neurochemistry | Neurology | Oxidative stress | Neuroprotection | Neurosciences | 6-hydroxydopamine | Biomedicine | Octadecaneuropeptide | Astrocytes | Cell death | Proteomics | Cell Biology | Biochemistry & Molecular Biology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Astrocytes - drug effects | Reactive Oxygen Species - metabolism | Rats, Wistar | Caspase 3 - metabolism | Cells, Cultured | Rats | Peptide Fragments - pharmacology | Antioxidants - pharmacology | Catalase - metabolism | Diazepam Binding Inhibitor - pharmacology | Oxidopamine - toxicity | Animals | Neuroprotective Agents - pharmacology | Neuropeptides - pharmacology | Superoxide Dismutase - metabolism | Apoptosis | Astrocytes - metabolism | Antioxidants | Enzymes | Nervous system diseases | Superoxide | Neurophysiology | Hydrogen peroxide | Transcription | Low concentrations | Peptides | Toxicity | Oligonucleotides | Superoxide dismutase | Caspase-3 | Time dependence | Mitochondria | Enzymatic activity | Catalase | Neurodegeneration | Peroxidase | Inhibition | Glutathione | Glutathione peroxidase | Neurodegenerative diseases | Incubation | Mortality | Caspase | Gene expression | Neurological diseases | Index Medicus | Medicinal Chemistry | Life Sciences | Neurons and Cognition | Neurobiology | Pharmacology | Cellular Biology | Chemical Sciences | Pharmaceutical sciences | Cell Behavior
Journal Article
Journal Article